Thermo Fisher Scientific Launches PPD CorEvitas Chronic Hand Eczema Registry

New Real-World Evidence Program Advances Research in Chronic Hand Eczema

Thermo Fisher Scientific has introduced the PPD™ CorEvitas™ Chronic Hand Eczema Registry, a prospective observational research program designed to generate high-quality real-world evidence on the management of chronic hand eczema (CHE). The registry will collect long-term clinical and patient-reported data from routine medical practice across North America, helping researchers, healthcare providers and biopharmaceutical companies gain deeper insights into disease progression, treatment patterns and patient outcomes.

Strengthening Real-World Clinical Research

Chronic hand eczema is a persistent inflammatory skin condition that can significantly affect daily activities, work productivity and quality of life. The newly launched registry is designed to capture comprehensive longitudinal data, enabling researchers to better understand how approved and emerging therapies perform in real-world clinical settings.

Capturing the Patient Experience

In addition to clinician-reported information, the registry incorporates patient-reported outcomes that evaluate symptoms, treatment experience, quality of life and work productivity. Early follow-up assessments after treatment initiation provide valuable information on short-term therapeutic response while supporting long-term monitoring of disease management strategies.

Supporting Future Dermatology Innovation

Real-world evidence is becoming increasingly important in clinical research, regulatory decision-making and healthcare planning. By establishing the Chronic Hand Eczema Registry, Thermo Fisher Scientific aims to provide researchers and healthcare organizations with reliable clinical data that can guide future therapeutic development, improve treatment strategies and enhance patient care.

Key Features

• PPD™ CorEvitas™ Chronic Hand Eczema Registry

• Prospective observational clinical registry

• Longitudinal real-world evidence collection

• Clinician- and patient-reported outcome measures

• Evaluation of treatment patterns and disease burden

• Monitoring of long-term treatment effectiveness

• Supports regulatory-grade clinical research

• Open to participating clinical sites in North America

Applications

• Dermatology clinical research

• Chronic hand eczema management

• Real-world evidence generation

• Clinical outcome assessment

• Pharmaceutical research and development

• Healthcare decision support

• Treatment effectiveness studies

• Regulatory and epidemiological research

Advancing Evidence-Based Dermatology

As healthcare increasingly relies on real-world clinical evidence to complement traditional clinical trials, comprehensive disease registries are becoming valuable research resources. Thermo Fisher Scientific's PPD CorEvitas Chronic Hand Eczema Registry is designed to improve understanding of chronic hand eczema by generating robust longitudinal data that supports scientific research, therapeutic innovation and evidence-based patient care.